Biotricity Research and Development Expenses 2015-2024 | BTCY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biotricity research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Biotricity Research and Development Expenses 2015-2024 | BTCY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biotricity research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$10.5B
Hims & Hers Health (HIMS)	$5.7B
Inspire Medical Systems (INSP)	$5.7B
Axonics (AXNX)	$3.6B
IRhythm Technologies (IRTC)	$2.7B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.6B
Omnicell (OMCL)	$2.3B
Azenta (AZTA)	$2.2B
10x Genomics (TXG)	$1.9B
Schrodinger (SDGR)	$1.6B
Clover Health Investments (CLOV)	$1.6B
Phreesia (PHR)	$1.2B
Standard BioTools (LAB)	$763M
Fulgent Genetics (FLGT)	$586M
Butterfly Network (BFLY)	$571M
Talkspace (TALK)	$569M
Definitive Healthcare (DH)	$528M
Health Catalyst (HCAT)	$495M
Pulmonx (LUNG)	$278M
SOPHiA GENETICS SA (SOPH)	$261M
TruBridge (TBRG)	$234M
P3 Health Partners (PIII)	$140M
American Well (AMWL)	$136M
EUDA Health Holdings (EUDA)	$98M
Future Health ESG (FHLT)	$65M
HeartBeam (BEAT)	$63M
111 (YI)	$56M
CareCloud (CCLD)	$51M
Zepp Health (ZEPP)	$49M